Analysis of drug absorption and retention in cancer cells for preclinical studies.

Isolation of a group of drugs with different physicochemical properties from cancer cells.

Repositioning of drugs using a new method of isolation and analysis from biological matrices.

The presented paper describes a new isolation method of recovery and analysis of selected drugs developed for preclinical research.

The method uses the RP-HPLC technique (in a single chromatographic separation) and serves the recovery and analysis of selected drugs from neoplastic cells. It enables the determination of cytostatics statins, fibrates, and pioglitazone. Chromatographic separations of the tested compounds were carried out on a Gemini-NX 5 µ C18 (4.6 × 150 mm i.d.) column, in a gradient system with a mobile phase consisting of ACN (0.1% TFA) and water (0.1% TFA) at ambient temperature. The separations were carried out at a flow of 1 ml/min and UV detection of 220 nm. The inter-day and intra-day precision and accuracy of the method were determined. Extending the extraction time at reduced temperature resulted in a significant increase in the recovery of the pharmaceuticals in comparison with traditional extraction methods.

The presence of the tested pharmaceuticals at defined retention times was confirmed by mass spectrometry. A recovery procedure for the tested compounds from biological material (medium, cell pellets) was developed at a level ranging between 93 and 99%. The utility of the new HPLC method has been confirmed in drug absorption studies as screening tests for the analysis of the new therapeutic compositions on melanoma cell lines.

Reversed-phase HPLC

Cytostatic drugs

Statins

Fibrates

Glitazones

No data was used for the research described in the article.

© 2022 The Author(s). Published by Elsevier B.V.